Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bjh.16938 http://scihub22266oqcxt.onion/10.1111/bjh.16938 32531085!7323335!32531085     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Haematol 2020 ; 190 (4): 520-524 Nephropedia Template TP {{tp|p=32531085|t=2020. C1 esterase inhibitor and the contact system in COVID-19 |pdf=|usr=}}{{32531085}} gab.com Text C1 esterase inhibitor and the contact system in COVID-19 JO: Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32531085 #FOAvip Coronavirus disease 2019 (COVID-19) is frequently associated with severe systemic consequences, including vasculitis, a hyperinflammatory state and hypercoagulation. The mechanisms leading to these life-threatening abnormalities are multifactorial. Based on the analysis of publicly available interactomes, we propose that severe acute respiratory syndrome coronavirus-2 infection directly causes a deficiency in C1 esterase inhibitor, a pathogen-specific mechanism that may help explain significant systemic abnormalities in patients with COVID-19. Twit Text FOAVip C1 esterase inhibitor and the contact system in COVID-19 ????Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32531085 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32531085 #FOAvip English Wikipedia <ref>{{Cite pmid|32531085}}</ref> C1 esterase inhibitor and the contact system in COVID-19 #MMPMID32531085 Thomson TM; Toscano-Guerra E; Casis E; Paciucci R Br J Haematol 2020[Aug]; 190 (4): 520-524 PMID32531085show ga Coronavirus disease 2019 (COVID-19) is frequently associated with severe systemic consequences, including vasculitis, a hyperinflammatory state and hypercoagulation. The mechanisms leading to these life-threatening abnormalities are multifactorial. Based on the analysis of publicly available interactomes, we propose that severe acute respiratory syndrome coronavirus-2 infection directly causes a deficiency in C1 esterase inhibitor, a pathogen-specific mechanism that may help explain significant systemic abnormalities in patients with COVID-19. |COVID-19/*metabolism/pathology[MESH] |Complement C1 Inhibitor Protein/*metabolism[MESH] |Humans[MESH]C1 esterase inhibitor and the contact system in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing